1/61
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
Critical
Crucial – Crisis – Emergency – Serious
Critical Care Nursing
care of the seriously-ill clients from point of injury/illness until discharge from intensive care
Deals with human responses to life-threatening problems
Comprehensive, specialized, and individualized nursing services which are rendered to patients with life-threatening conditions
Role of a Critical Care Nurse:
Care for clients who are very ill
Provide one-to-one care
Responsible of making life and death decision
At risk of injury and illness
COMMUNICATION SKILL is of optimum importance
Goal of a Critical Care Nurse:
Survival of the critically-ill patients and
Restoring QUALITY of LIFE
Helping families of critically-ill patients in coping with stress
Coronary artery disease (CAD)
is a chronic condition characterized by plaque buildup in the coronary arteries
Acute coronary syndrome (ACS) definition
is a sudden, severe reduction in blood flow to the heart, potentially leading to a heart attack or unstable angina, and is a manifestation of CAD
ACUTE CORONARY SYNDROME (ACS)
includes a constellation of syndromes:
Chest pain
Unstable angina
Non ST elevation MI ( Non-STEMI )
ST elevation ( STEMI )
Mortality rates and the risk associated with ACS is greatest during the first 30 days after presentation
early diagnosis and treatment is imperative
Pathophysiology of Acute Coronary Syndrome
Late signs and symptoms of:
Stable angina
Unstable angina
Atherothrombosis
Coronary artery with atherosclerotic plaque. The core of the atherosclerotic plaque contains inflammatory cells and lipids, which sustain chronic inflammation in the arterial wall.
The atherosclerotic plaque is vulnerable (unstable). A rupture or erosion can damage its fibrous cap, releasing highly thrombogenic material. This activates platelets and coagulation factors.
The activation of platelets and coagulation factors leads to the formation of a thrombus (atherothrombosis). The myocardium supplied by this artery becomes ischemic. If blood flow is not restored within 30 minutes, necrosis occurs.
Triad of I’s in ACS
Ischemia
Injury
Infarct
IT ALL REPRESENT OXYGEN SUPPLY PROBLEM
Ischemia
reversible
Injury
acute injury of both ischemia and infarct
Infarction
irreversible cell death
ACS History of Presenting Illness:
The most important diagnostic information is the patient’s “ story “
current symptoms
time of onset
pain assessment
past medical history / medications
ACS “Typical” Signs and Symptoms of MI
Chest discomfort:
Crushing, pressure, tightness
sustained
Partially or unrelieved by rest
Partially or unrelieved by NTG
Pain radiates to Left arm shoulder and
ACS Associated Signs and Symptoms of MI
Chest discomfort
Denial
Syncope / weakness
Cool/pale/diaphoretic
Dyspnea
N/V
Sense of impending doom
Unstable Angina/Non ST-Segment Elevation MI
Diagnosis:
pain severity & presenting symptoms
ECG findings
serum cardiac markers
When chest pain has been unremitting for >20mins
possibility of ST-Segment Elevation MI
Non-ST Elevation Myocardial Infarction (Non-STEMI)
Differs from unstable angina mostly due to severity of ischemia
Non-STEMI causes enough myocardial damage to release detectable cardiac markers indicating myocardial injury
Troponin I
Troponin T
Creatinine kinase (CK-MB)
ECG changes may occur
No sustained ST segment elevation
Can limit the area of infarction through medical and nursing interventions
ST Elevation Myocardial Infarction (STEMI)
Loss of cardiac myocytes as a result of prolonged ischemia
Myocardial ischemia does not cause immediate cell death
It takes at least 4 to 6 hours for complete necrosis
This is dependent upon the presence of collateral blood flow into the ischemic zone or coronary artery occlusion
ST-Segment Elevation MI (Heart Attack) Diagnosis:
based on presenting S/Sx
serum markers
ECG
changes may not be present immediately after symptoms except dysrhythmias;
PVCs (Premature Ventricular Contractions) are common after MI
ST-Segment Elevation MI (Heart Attack) is Characterized by?
ischemic death of myocardial tissue associated with atherosclerotic disease of coronary arteries
Area of infarction is determined by the affected coronary artery & its distribution of blood flow
right coronary artery
left anterior descending artery
left circumflex artery
ACS Goal
Early Reperfusion Therapy
ACS Reperfusion Therapy Outcomes Dependent Upon
Time to treatment
Early and full restoration of blood flow
Reperfusion Therapy
Fibrinolytic therapy
PTCA
Management of MI
Morphine
Analgesia via IV
vasodilator property also
Oxygen therapy via nasal prongs
NTG (unless contraindicated)
SL
IV may be given to limit infarction size
most effective if given within 4hrs of onset
Anticoagulants & Antiplatelets:
Heparin, ASA
Thrombolytic Therapy
best results occur if initiated within 60-90mins of onset
Streptokinase & Urokinase –promote conversion of plasminogen to plasmin
Anti-arrhythmics
Lidocaine
Atropine
Propranolol
Stool softeners
ECG monitoring
HYPERTENSIVE CRISIS
is any clinical condition requiring immediate reduction in BP.
is an acute and life threatening condition.
The accelerated hypertension requires emergency treatment because target organ damage (brain, heart, kidneys, retina of the eye) can occur quickly.
Death can be caused by stroke, kidney failure, or cardiac disease.
HYPERTENSIVE CRISIS ASSESSMENT
An extremely high BP; usually the diastolic
pressure is higher than 120 mm Hg
Headache
Drowsiness and confusion
Blurred vision
Changes in neurological status
Tachycardia and tachypnea
Dyspnea
Cyanosis
Seizures
HYPERTENSIVE CRISIS NURSING INTERVENTIONS
Maintain a patent airway.
Administer antihypertensive medications
intravenously as prescribed.
Monitor vital signs, assessing the BP every 5 minutes.
Maintain bed rest, with the HOB elevated at 45 degrees.
Assess for hypotension during the administration of antihypertensives; place the client in a supine position if hypotension occurs.
Have emergency medications and resuscitation equipment readily available.
Monitor IV therapy, assessing for fluid overload.
Insert a Foley catheter as prescribed.
Monitor intake and urinary output; if oliguria or anuria occurs, notify the HCP.
PULMONARY EMBOLISM
This is a thrombotic or non-thrombotic embolus that lodges in the pulmonary artery system.
It can damage part of the lung due to;
restricted blood flow
hypoxemia
affect other organs as well.
can be life-threatening
PULMONARY EMBOLISM RISK FACTORS
Injury or damage leading to blood clot formation
Inactivity for prolonged periods
Medical conditions or treatment procedures that cause blood to clot easily e.g. surgery DVT
PULMONARY EMBOLISM CAUSES
Clinical Manifestations
Virchow’s triad:
venous stasis,
coagulation problems,
vessel wall injury
Chest pain
Tachycardia, tachypnea
Anxiety, restlessness
Clammy or bluish skin
PULMONARY EMBOLISM DIAGNOSTICS
CXR
ABG analysis
D-dimer test
detects clot fragments from clot lysis
ECG
V/Q scan / Pulmonary angiography/ spiral CT scan
PULMONARY EMBOLISM TREATMENT
Oxygenation
= ET and mechanical ventilation
Heparin therapy
Surgery
= umbrella filter
= pulmonary embolectomy
Prevention of development of DVT
ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS)
This is a syndrome with
inflammation and
increased permeability of the alveolocapillary membrane
occurs as a result of an injury to the lungs.
fatal when left undiagnosed or treated for 48hrs.
Increase permeability of alveolo-capillary membrane
ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) RISK FACTORS
Critically ill patients
Age (60y/o and above)
Malignancy (cancers)
Cigarette smoking, COPD
Direct Cause of ARDS
drowning
Indirect Cause of ARDS
drug overdose
burns
shock
COMMON CAUSES OF ARDS
Aspiration
Acute Pancreatitis
Air Embolism
Drug Overdose
Diffuse Lung Disease
Drowning
Radiation
Shock
Sepsis
Smoke Inhalation
STAGES OF ARDS
Exudative Phase
Proliferative
Fibrotic
EXUDATIVE PHASE
24 h after injury
damage to the capillary membrane
leak of fluid and CHON
pulmonary edema
damaged surfactants
HYPOXEMIA = hallmark
Inc RR, dec CO2
PROLIFERATIVE
14 days after
Grow and reproduce
Repair structure
Reabsorption fluid
Very dense and fibrous tissue
HYPOXEMIA = worse
FIBROTIC
3 weeks after injury
fibrosis of lung tissue
major lung damage
dead space in lungs
poor prognosis
Respiratory alkalosis
NOT all patients enter this
ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) CLINICAL MANIFESTATIONS
Signs and symptoms are often exhibited within 24-48 hours after initial insult to the lungs
Restlessness
Hyperventilation, tachycardia, SOB
Hypoxemia
Severe: hypotension, cyanosis, decreased UO
ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) RISK FACTORS
Old age
Smoking
Drinking
ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) DIAGNOSTICS
After a pulse is found, a blood sample is taken from the artery
Diagnostics
chest x-ray
white out lungs
ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) TREATMENT & GOALS
Goal: → improving and maintaining oxygenation and prevent respiratory and metabolic complications
Fluid management to maintain tissue perfusion
Corticosteroid therapy to decrease permeability of the alveolocapillary
Goal: → improving and maintaining oxygenation and prevent respiratory and metabolic complications
Nutrition – enteral feeding
Supplemental oxygen
Mechanical Ventilation
a form of artificial ventilation that takes over all or part of the work performed by the respiratory muscles and organs
Modes, Settings, Alarms
Major Liver Functions
Biotransformation
Storage
Synthesis
Major Liver Functions: Biotransformation
Ammonia
Hemoglobin
Drugs
Xenobiotics
Glucose
Major Liver Functions: Storage
Vitamins
Glycogen
Lipids
Major Liver Functions: Synthesis
Albumin
Growth factors
Urea
Liver Normal Function
Stores glycogen
Synthesizes proteins
Synthesizes globulins
Synthesizes clotting factors
Secretes BILES
Converts ammonia to urea
Stores Vit and minerals
Metabolizes estrogen
Liver Failure is also known as?
Hepatic Failure
a condition in which the organ fails to fulfill its functions or is unable to meet the demands placed upon it.
Signs of liver disease
Jaundice
Easy bleeding or bruising
Ascites
Esophageal varices
Complication:
bleeding
Others:
Jaundice (yellow skin and eyes)
Encephalopathy (confusion)
Spider angioma
Lack of body hair
Muscle wasting
Widened blood vessels
Ascites (fluid buildup)
Red palms
COMPLICATIONS: CIRRHOSIS
Portal Hypertension
persistent increase in pressure in the portal vein that develops as a result of obstruction to flow
Ascites
results from venous congestion of the hepatic capillaries
Accumulation of fluid in the peritoneal cavity
leads to plasma leaking directly from the liver surface and portal vein.
Bleeding esophageal varices
Fragile, thin-walled, distended esophageal veins that become irritated and rupture
Esophageal Varices Symptoms
hematemesis
melena
light headedness
loss of consciousness in severe cases
Treatment: Esophageal Varices
Esophageal varices
Vasopressin
first line treatment
Use of Balloon Tamponade
Sengstaken-Blakemore
Minnesota tubes
First-line treatment to decrease bleeding
volume replacement
especially for signs of shock
IV fluid and / or blood products
Gastric lavage
Blood transfusion
Limit: Hemoglobin level of 7 g/dL
Prophylactic Antibiotic
IV Ceftriaxone 1 gm daily x 7 days
Oral Norfloxacin 400 mg BID x 7 days
Liver transplant
Treatment: Re-Bleeding - Esophageal Varices
Beta blocker
Non-selective beta-blockers (NSBBs)
cornerstone of treatment for prevention of first bleeding and rebleeding of esophageal varices in patients with cirrhosis
Propranolol
Nadolol
Timolol
Carvedilol
a new NSBB that is increasingly used
has a greater portal pressure reducing effect than propranolol
safe in patients with compensated and decompensated cirrhosis
Endoscopic Band Ligation
COMPLICATIONS: CIRRHOSIS
Coagulation defects
Decreased synthesis of bile fats in the liver prevents the absorption of fat-soluble vitamins.
Without vitamin K and clotting factors II, VII, IX, and X, the client is prone to bleeding.
Hepatic Encephalopathy
End-stage hepatic failure
Hepatic Encephalopathy Pathophysiology
Brain impairment due to diminished liver function
Underlying causes:
Increased levels of ammonia
Diminished cellular energy supplies
Change in blood-brain barrier permeability
Cirrhosis Treatment goals:
Identification of cause
Correct the cause or
Slow progression
Supportive therapy
Lactulose
Neomycin
Hepatic Encephalopathy - Management:
Mainly supportive
Ensure that LOC status is not from other cause
Check blood glucose levels
Assess for trauma and overdose
Take a medical history
Monitor asterixis
Hepatic Encephalopathy - Pharmacotherapeutics:
Lactulose
decreases the pH of the bowel
decreases production of ammonia by bacteria in the bowel
facilitates the excretion of ammonia.
Neomycin
inhibit protein synthesis in bacteria and decrease the production of ammonia.